Patents by Inventor Sandrine Seguret

Sandrine Seguret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT VIRUSES EXPRESSING LECITHIN-CHOLESTEROL ACYLTRANSFERASE, AND USES THEREOF IN GENE THERAPY
    Publication number: 20010014319
    Abstract: Defective recombinant viruses containing an inserted gene coding for all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof, pharmaceutical compositions containing said viruses, and the use thereof for treating or preventing dyslipoproteinaemia-related diseases, are disclosed.
    Type: Application
    Filed: November 5, 1997
    Publication date: August 16, 2001
    Applicant: RHONE-POULENC RORER S.A.
    Inventors: PATRICE DENEFLE, NICOLAS DUVERGER, MARTINE LATTA-MAHIEU, SANDRINE SEGURET
  • Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
    Patent number: 5866551
    Abstract: The present invention concerns defective recombinant adenoviruses containing an inserted gene encoding apolipoproteins, pharmaceutical compositions comprising the adenovirus, and their use for the treatment or prevention of pathologies linked to dyslipoproteinemias.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: February 2, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Patrick Benoit, Patrice Denefle, Michel Perricaudet, Sandrine Seguret, Emmanuelle Vigne
  • Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
    Patent number: RE38556
    Abstract: The present invention concerns defective recombinant adenoviruses containing an inserted gene encoding apolipoproteins, pharmaceutical compositions comprising the adenovirus, and their use for the treatment or prevention of pathologies linked to dyslipoproteinemias.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: July 13, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Patrick Benoit, Patrice Denefle, Michel Perricaudet, Sandrine Seguret, Emmanuelle Vigne